The Percept™ family: engineered to adapt with BrainSense™ technology†

Empowering patient freedom with patient-first capabilities for flexibility and convenience

Enabling personalization with data-driven insights that allow you to adapt therapy to your patients‘ needs

Designed for upgradability and engineered to allow for future software updates for the Percept™ platform without a neurostimulator device exchange

Percept™ PC neurostimulator

The recharge-free model blends ergonomic design with cutting-edge battery technology.

Ergonomic design Percept™ PC neurostimulator is designed for comfort, with the thinnest PC on the market.‡,1-3
Designed to last The Percept™ PC device has a projected mean longevity >5 years for median energy-user§ and features smart battery technology offering real-time estimation of battery longevity◊ to keep your patients informed.
Designed to adapt BrainSense™ technology† and advanced programming capabilities let you personalize therapy to your patients' evolving needs over time. 
Broad indication coverage Indicated for Parkinson’s disease, essential tremor, epilepsy, dystonia and obsessive-compulsive disorder

 

Humanitarian device: The effectiveness of these devices for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.

See Percept™ PC details

Percept™ RC neurostimulator

Meet the newest member of the Percept™ family. Percept™ RC offers patients a rechargeable version specifically designed to be:

Small

Patient comfort

The smallest, rechargeable, DBS device available.
Smart

Rapid recharging

Patients can charge under normal conditions (from 10% to 90% full) in less than an hour.#

With more than 99% capacity at 15 years with weekly recharge, it is designed to offer a more consistent recharge experience over time.
Adaptive

Designed to adapt

BrainSense™ technology† and advanced programming capabilities allow you to personalize therapy to your patients’ evolving needs over time.
Broad indication coverage Indicated for Parkinson’s disease, essential tremor, epilepsy, and dystonia

 

Humanitarian device: The effectiveness of these devices for the treatment of dystonia has not been demonstrated.

See Percept™ RC details

BrainSense™ technology allows you to adapt to patient needs over time with data-driven insights.

Percept™ family with exclusive BrainSense™ technology

  • Uses local field potentials (LFPs) as a signal of interest that can be tracked with responses to deep brain stimulation (DBS) therapy and medications
  • Offers data-driven insights into the patient’s condition, enabling clinicians to adapt DBS to a patient’s needs
  • Engineered for future software updates that allow patients to have access to additional features without a device exchange
Read more about BrainSense™ technology

BrainSense™ technology offers decision-making support to select and optimize programming configurations and maximize therapeutic results over time.

A vast majority of patients with Parkinson’s disease have a detectable signal (LFP).4

92%

have a detectable signal in an “off-medication” state4

87%

of brain hemispheres have a detectable signal in an “on-medication” state4


15+ years

of research has informed BrainSense™ technology

Medtronic MRI advantage.∆ Always on.

Your DBS patient may need an MRI.

~10M

scans in the U.S. performed annually5

77%

MRI scans ordered globally are not brain related.6

1 in 8

women will develop breast cancer7

Full-body MRI access∆

  • Medtronic offers greater freedom and scan access with 3T scans and best-in-class 1.5T full system MRI scan labeling8–10 for directional leads.
  • Medtronic DBS is the only DBS system that doesn‘t keep a patient from receiving the care they need when having an MRI.8–10
See MRI details